156 related articles for article (PubMed ID: 15026356)
1. CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells.
Su CC; Chiu HH; Chang CC; Chen JC; Hsu SM
Cancer Res; 2004 Mar; 64(6):2148-52. PubMed ID: 15026356
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
Heuser C; Diehl V; Abken H; Hombach A
Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650
[TBL] [Abstract][Full Text] [Related]
3. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
4. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
[TBL] [Abstract][Full Text] [Related]
5. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
Ohsawa M; Aozasa K; Ikeda H
Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
[TBL] [Abstract][Full Text] [Related]
7. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
Kim LH; Eow GI; Peh SC; Poppema S
Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
[TBL] [Abstract][Full Text] [Related]
8. Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies.
Falini B; Stein H; Pileri S; Canino S; Farabbi R; Martelli MF; Grignani F; Fagioli M; Minelli O; Ciani C
Histopathology; 1987 Dec; 11(12):1229-42. PubMed ID: 2831131
[TBL] [Abstract][Full Text] [Related]
9. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
J Immunother; 1999 Nov; 22(6):473-80. PubMed ID: 10570745
[TBL] [Abstract][Full Text] [Related]
13. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
Schmid C; Pan L; Diss T; Isaacson PG
Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease.
Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK
Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624
[TBL] [Abstract][Full Text] [Related]
15. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
16. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
18. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
[TBL] [Abstract][Full Text] [Related]
19. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Reynolds DJ; Banks PM; Gulley ML
Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]